Clinical Next-Generation Sequencing Market Report

China Clinical Next-Generation Sequencing Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • POSTDATE：Aug 22, 2022
  • PAGES：203
  • REPORT CODE：GMM1097965
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Next-generation sequencing (NGS) has been rapidly integrated into molecular pathology, dramatically increasing the breadth genomic of information available to oncologists and their patientseration sequencing.

    This report offers an overview of the market trends, drivers, and barriers with respect to the China Clinical Next-Generation Sequencing market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Clinical Next-Generation Sequencing market. Detailed analysis of key players, along with key growth strategies adopted by Clinical Next-Generation Sequencing industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • Company 1

    • Company 2

    • Company 3

    • Company 4

    • Company 5

    • Company 6

    • Company 7

    • Company 8

    • Company 9

    • Company 10

    By Type:

    • Targeted Sequencing

    • Exome Sequencing

    • Others

    By End-User:

    • Hospitals and Clinics

    • Biopharma Companies

    • Academic and Research Organizations

    • Others

    By Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Clinical Next-Generation Sequencing Market

    • 1.3 Market Segment by Type

    • 1.3.1 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Targeted Sequencing from 2016 to 2027

    • 1.3.2 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Exome Sequencing from 2016 to 2027

    • 1.3.3 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.4 Market Segment by Application

    • 1.4.1 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Hospitals and Clinics from 2016 to 2027

    • 1.4.2 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Biopharma Companies from 2016 to 2027

    • 1.4.3 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Academic and Research Organizations from 2016 to 2027

    • 1.4.4 China Clinical Next-Generation Sequencing Market Size and Growth Rate of Others from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 North China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Central China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 South China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 East China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.5 Northeast China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.6 Southwest China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.7 Northwest China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Clinical Next-Generation Sequencing Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Clinical Next-Generation Sequencing by Major Types

    • 3.4.1 Market Size and Growth Rate of Targeted Sequencing

    • 3.4.2 Market Size and Growth Rate of Exome Sequencing

    • 3.4.3 Market Size and Growth Rate of Others

    4 Segmentation of Clinical Next-Generation Sequencing Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Clinical Next-Generation Sequencing by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Clinical Next-Generation Sequencing in Hospitals and Clinics

    • 4.4.2 Market Size and Growth Rate of Clinical Next-Generation Sequencing in Biopharma Companies

    • 4.4.3 Market Size and Growth Rate of Clinical Next-Generation Sequencing in Academic and Research Organizations

    • 4.4.4 Market Size and Growth Rate of Clinical Next-Generation Sequencing in Others

    5 Market Analysis by Regions

    • 5.1 China Clinical Next-Generation Sequencing Production Analysis by Regions

    • 5.2 China Clinical Next-Generation Sequencing Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on China Economy

    6 North China Clinical Next-Generation Sequencing Landscape Analysis

    • 6.1 North China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 6.2 North China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    7 Central China Clinical Next-Generation Sequencing Landscape Analysis

    • 7.1 Central China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 7.2 Central China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    8 South China Clinical Next-Generation Sequencing Landscape Analysis

    • 8.1 South China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 8.2 South China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    9 East China Clinical Next-Generation Sequencing Landscape Analysis

    • 9.1 East China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 9.2 East China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    10 Northeast China Clinical Next-Generation Sequencing Landscape Analysis

    • 10.1 Northeast China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 10.2 Northeast China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    11 Southwest China Clinical Next-Generation Sequencing Landscape Analysis

    • 11.1 Southwest China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 11.2 Southwest China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    12 Northwest China Clinical Next-Generation Sequencing Landscape Analysis

    • 12.1 Northwest China Clinical Next-Generation Sequencing Landscape Analysis by Major Types

    • 12.2 Northwest China Clinical Next-Generation Sequencing Landscape Analysis by Major End-Users

    13 Major Players Profiles

    • 13.1 Company 1

      • 13.1.1 Company 1 Company Profile and Recent Development

      • 13.1.2 Market Performance

      • 13.1.3 Product and Service Introduction

    • 13.2 Company 2

      • 13.2.1 Company 2 Company Profile and Recent Development

      • 13.2.2 Market Performance

      • 13.2.3 Product and Service Introduction

    • 13.3 Company 3

      • 13.3.1 Company 3 Company Profile and Recent Development

      • 13.3.2 Market Performance

      • 13.3.3 Product and Service Introduction

    • 13.4 Company 4

      • 13.4.1 Company 4 Company Profile and Recent Development

      • 13.4.2 Market Performance

      • 13.4.3 Product and Service Introduction

    • 13.5 Company 5

      • 13.5.1 Company 5 Company Profile and Recent Development

      • 13.5.2 Market Performance

      • 13.5.3 Product and Service Introduction

    • 13.6 Company 6

      • 13.6.1 Company 6 Company Profile and Recent Development

      • 13.6.2 Market Performance

      • 13.6.3 Product and Service Introduction

    • 13.7 Company 7

      • 13.7.1 Company 7 Company Profile and Recent Development

      • 13.7.2 Market Performance

      • 13.7.3 Product and Service Introduction

    • 13.8 Company 8

      • 13.8.1 Company 8 Company Profile and Recent Development

      • 13.8.2 Market Performance

      • 13.8.3 Product and Service Introduction

    • 13.9 Company 9

      • 13.9.1 Company 9 Company Profile and Recent Development

      • 13.9.2 Market Performance

      • 13.9.3 Product and Service Introduction

    • 13.10 Company 10

      • 13.10.1 Company 10 Company Profile and Recent Development

      • 13.10.2 Market Performance

      • 13.10.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Targeted Sequencing from 2016 to 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Exome Sequencing from 2016 to 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2021

    • Figure Market Share by Type in 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Hospitals and Clinics from 2016 to 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Biopharma Companies from 2016 to 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Academic and Research Organizations from 2016 to 2027

    • Figure China Clinical Next-Generation Sequencing Market Size and Growth Rate of Others from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2021

    • Figure Market Share by End-User in 2027

    • Figure North China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Central China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure East China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Clinical Next-Generation Sequencing Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2021

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Map of China

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Clinical Next-Generation Sequencing

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Clinical Next-Generation Sequencing by Different Types from 2016 to 2027

    • Table Consumption Share of Clinical Next-Generation Sequencing by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Targeted Sequencing

    • Figure Market Size and Growth Rate of Exome Sequencing

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Clinical Next-Generation Sequencing by Different End-Users from 2016 to 2027

    • Table Consumption Share of Clinical Next-Generation Sequencing by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Hospitals and Clinics

    • Figure Market Size and Growth Rate of Biopharma Companies

    • Figure Market Size and Growth Rate of Academic and Research Organizations

    • Figure Market Size and Growth Rate of Others

    • Table China Clinical Next-Generation Sequencing Production by Regions

    • Table China Clinical Next-Generation Sequencing Production Share by Regions

    • Figure China Clinical Next-Generation Sequencing Production Share by Regions in 2016

    • Figure China Clinical Next-Generation Sequencing Production Share by Regions in 2021

    • Figure China Clinical Next-Generation Sequencing Production Share by Regions in 2027

    • Table China Clinical Next-Generation Sequencing Consumption by Regions

    • Table China Clinical Next-Generation Sequencing Consumption Share by Regions

    • Figure China Clinical Next-Generation Sequencing Consumption Share by Regions in 2016

    • Figure China Clinical Next-Generation Sequencing Consumption Share by Regions in 2021

    • Figure China Clinical Next-Generation Sequencing Consumption Share by Regions in 2027

    • Table North China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table North China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table North China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table North China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure North China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table Central China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table Central China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table Central China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table Central China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure Central China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table South China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table South China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table South China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table South China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure South China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table East China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table East China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table East China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table East China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure East China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table Northeast China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table Northeast China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table Northeast China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table Northeast China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure Northeast China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table Southwest China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table Southwest China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table Southwest China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table Southwest China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure Southwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table Northwest China Clinical Next-Generation Sequencing Consumption by Types from 2016 to 2027

    • Table Northwest China Clinical Next-Generation Sequencing Consumption Share by Types from 2016 to 2027

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2016

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2021

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by Types in 2027

    • Table Northwest China Clinical Next-Generation Sequencing Consumption by End-Users from 2016 to 2027

    • Table Northwest China Clinical Next-Generation Sequencing Consumption Share by End-Users from 2016 to 2027

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2016

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2021

    • Figure Northwest China Clinical Next-Generation Sequencing Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of Company 1

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 1

    • Figure Sales and Growth Rate Analysis of Company 1

    • Figure Revenue and Market Share Analysis of Company 1

    • Table Product and Service Introduction of Company 1

    • Table Company Profile and Development Status of Company 2

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 2

    • Figure Sales and Growth Rate Analysis of Company 2

    • Figure Revenue and Market Share Analysis of Company 2

    • Table Product and Service Introduction of Company 2

    • Table Company Profile and Development Status of Company 3

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 3

    • Figure Sales and Growth Rate Analysis of Company 3

    • Figure Revenue and Market Share Analysis of Company 3

    • Table Product and Service Introduction of Company 3

    • Table Company Profile and Development Status of Company 4

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 4

    • Figure Sales and Growth Rate Analysis of Company 4

    • Figure Revenue and Market Share Analysis of Company 4

    • Table Product and Service Introduction of Company 4

    • Table Company Profile and Development Status of Company 5

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 5

    • Figure Sales and Growth Rate Analysis of Company 5

    • Figure Revenue and Market Share Analysis of Company 5

    • Table Product and Service Introduction of Company 5

    • Table Company Profile and Development Status of Company 6

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 6

    • Figure Sales and Growth Rate Analysis of Company 6

    • Figure Revenue and Market Share Analysis of Company 6

    • Table Product and Service Introduction of Company 6

    • Table Company Profile and Development Status of Company 7

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 7

    • Figure Sales and Growth Rate Analysis of Company 7

    • Figure Revenue and Market Share Analysis of Company 7

    • Table Product and Service Introduction of Company 7

    • Table Company Profile and Development Status of Company 8

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 8

    • Figure Sales and Growth Rate Analysis of Company 8

    • Figure Revenue and Market Share Analysis of Company 8

    • Table Product and Service Introduction of Company 8

    • Table Company Profile and Development Status of Company 9

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 9

    • Figure Sales and Growth Rate Analysis of Company 9

    • Figure Revenue and Market Share Analysis of Company 9

    • Table Product and Service Introduction of Company 9

    • Table Company Profile and Development Status of Company 10

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Company 10

    • Figure Sales and Growth Rate Analysis of Company 10

    • Figure Revenue and Market Share Analysis of Company 10

    • Table Product and Service Introduction of Company 10


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US